3,3,5-Trimethylcyclohexyl acetate
Common Name: |
3,3,5-Trimethylcyclohexyl acetate |
IUPAC Name: |
(3,3,5-trimethylcyclohexyl) acetate |
Molecular Formula: |
C11H20O2 |
SMILES: |
CC1CC(CC(C1)(C)C)OC(=O)C |
Inchi: |
1S/C11H20O2/c1-8-5-10(13-9(2)12)7-11(3,4)6-8/h8,10H,5-7H2,1-4H3 |
Inchi Key: |
OIVWFAFCHQDCCG-UHFFFAOYSA-N |
Cas No: |
67859-96-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
184.28 |
Mass (g/mol) |
184.146 |
Molar Refractivity |
53.90 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
13 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
83.00 @ 2.00 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.199 |
Vapor Density (Air =1) |
>1 |
Fraction Csp3 |
0.91 |
LogP |
2.764 |
iLOGP |
2.52 |
XLOGP3 |
-0.16 |
WLOGP |
2.76 |
MLOGP |
2.48 |
ESOL Log S |
-0.75 |
ESOL Solubility (mg/ml) |
32.8 |
ESOL Solubility (mol/l) |
0.178 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
0.06 |
Ali Solubility (mg/ml) |
213 |
Ali Solubility (mol/l) |
1.15 |
Ali Class |
Highly soluble |
Silicos-IT LogSw |
-2.31 |
Silicos-IT Solubility (mg/ml) |
0.9 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-7.54 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.778 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.136 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Warning |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |